These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 27796716)
21. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Lubinski J Breast Cancer Res Treat; 2010 Jun; 121(3):639-49. PubMed ID: 19876733 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Osorio A; Milne RL; Pita G; Peterlongo P; Heikkinen T; Simard J; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Healey S; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Lindor N; Manoukian S; Barile M; Viel A; Tizzoni L; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai P; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; Weerasooriya N; ; Gerdes AM; Thomassen M; Cruger DG; Caligo MA; Friedman E; Kaufman B; Laitman Y; Cohen S; Kontorovich T; Gershoni-Baruch R; Dagan E; Jernström H; Askmalm MS; Arver B; Malmer B; ; Domchek SM; Nathanson KL; Brunet J; Ramón Y Cajal T; Yannoukakos D; Hamann U; ; Hogervorst FB; Verhoef S; Gómez García EB; Wijnen JT; van den Ouweland A; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Cook J; Hodgson S; Morrison PJ; Douglas F; Godwin AK; ; Sinilnikova OM; Barjhoux L; Stoppa-Lyonnet D; Moncoutier V; Giraud S; Cassini C; Olivier-Faivre L; Révillion F; Peyrat JP; Muller D; Fricker JP; Lynch HT; John EM; Buys S; Daly M; Hopper JL; Terry MB; Miron A; Yassin Y; Goldgar D; ; Singer CF; Gschwantler-Kaulich D; Pfeiler G; Spiess AC; Hansen TV; Johannsson OT; Kirchhoff T; Offit K; Kosarin K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Varon-Mateeva R; Schaefer D; Froster UG; Caldes T; de la Hoya M; McGuffog L; Antoniou AC; Nevanlinna H; Radice P; Benítez J; Br J Cancer; 2009 Dec; 101(12):2048-54. PubMed ID: 19920816 [TBL] [Abstract][Full Text] [Related]
23. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Zeng C; Guo X; Long J; Kuchenbaecker KB; Droit A; Michailidou K; Ghoussaini M; Kar S; Freeman A; Hopper JL; Milne RL; Bolla MK; Wang Q; Dennis J; Agata S; Ahmed S; Aittomäki K; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Arun BK; Arver B; Bacot F; Barrowdale D; Baynes C; Beeghly-Fadiel A; Benitez J; Bermisheva M; Blomqvist C; Blot WJ; Bogdanova NV; Bojesen SE; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brennan P; Brenner H; Broeks A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldes T; Campbell I; Carpenter J; Chang-Claude J; Choi JY; Claes KB; Clarke C; Cox A; Cross SS; Czene K; Daly MB; de la Hoya M; De Leeneer K; Devilee P; Diez O; Domchek SM; Doody M; Dorfling CM; Dörk T; Dos-Santos-Silva I; Dumont M; Dwek M; Dworniczak B; Egan K; Eilber U; Einbeigi Z; Ejlertsen B; Ellis S; Frost D; Lalloo F; ; Fasching PA; Figueroa J; Flyger H; Friedlander M; Friedman E; Gambino G; Gao YT; Garber J; García-Closas M; Gehrig A; Damiola F; Lesueur F; Mazoyer S; Stoppa-Lyonnet D; ; Giles GG; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Haiman CA; Hallberg E; Hamann U; Hansen TV; Hart S; Hartikainen JM; Hartman M; Hassan N; Healey S; Hogervorst FB; Verhoef S; ; Hendricks CB; Hillemanns P; Hollestelle A; Hulick PJ; Hunter DJ; Imyanitov EN; Isaacs C; Ito H; Jakubowska A; Janavicius R; Jaworska-Bieniek K; Jensen UB; John EM; Joly Beauparlant C; Jones M; Kabisch M; Kang D; Karlan BY; Kauppila S; Kerin MJ; Khan S; Khusnutdinova E; Knight JA; Konstantopoulou I; Kraft P; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Le Marchand L; Lee CN; Lee MH; Lester J; Li J; Liljegren A; Lindblom A; Lophatananon A; Lubinski J; Mai PL; Mannermaa A; Manoukian S; Margolin S; Marme F; Matsuo K; McGuffog L; Meindl A; Menegaux F; Montagna M; Muir K; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Newcomb PA; Nord S; Nussbaum RL; Offit K; Olah E; Olopade OI; Olswold C; Osorio A; Papi L; Park-Simon TW; Paulsson-Karlsson Y; Peeters S; Peissel B; Peterlongo P; Peto J; Pfeiler G; Phelan CM; Presneau N; Radice P; Rahman N; Ramus SJ; Rashid MU; Rennert G; Rhiem K; Rudolph A; Salani R; Sangrajrang S; Sawyer EJ; Schmidt MK; Schmutzler RK; Schoemaker MJ; Schürmann P; Seynaeve C; Shen CY; Shrubsole MJ; Shu XO; Sigurdson A; Singer CF; Slager S; Soucy P; Southey M; Steinemann D; Swerdlow A; Szabo CI; Tchatchou S; Teixeira MR; Teo SH; Terry MB; Tessier DC; Teulé A; Thomassen M; Tihomirova L; Tischkowitz M; Toland AE; Tung N; Turnbull C; van den Ouweland AM; van Rensburg EJ; Ven den Berg D; Vijai J; Wang-Gohrke S; Weitzel JN; Whittemore AS; Winqvist R; Wong TY; Wu AH; Yannoukakos D; Yu JC; Pharoah PD; Hall P; Chenevix-Trench G; ; ; Dunning AM; Simard J; Couch FJ; Antoniou AC; Easton DF; Zheng W Breast Cancer Res; 2016 Jun; 18(1):64. PubMed ID: 27459855 [TBL] [Abstract][Full Text] [Related]
25. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. Barnes DR; Antoniou AC J Intern Med; 2012 Apr; 271(4):331-43. PubMed ID: 22443199 [TBL] [Abstract][Full Text] [Related]
26. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Hamdi Y; Soucy P; Adoue V; Michailidou K; Canisius S; Lemaçon A; Droit A; Andrulis IL; Anton-Culver H; Arndt V; Baynes C; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brenner H; Broeks A; Burwinkel B; Chang-Claude J; ; Couch FJ; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Devilee P; Dörk T; Dos-Santos-Silva I; Eriksson M; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Goldberg MS; González-Neira A; Grenaker-Alnæs G; Guénel P; Haeberle L; Haiman CA; Hamann U; Hallberg E; Hooning MJ; Hopper JL; Jakubowska A; Jones M; Kabisch M; Kataja V; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Maranian M; Margolin S; Marme F; Milne RL; Neuhausen SL; Nevanlinna H; Neven P; Olswold C; Peto J; Plaseska-Karanfilska D; Pylkäs K; Radice P; Rudolph A; Sawyer EJ; Schmidt MK; Shu XO; Southey MC; Swerdlow A; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Van Den Ouweland AM; Wang Q; Winqvist R; ; Zheng W; Benitez J; Chenevix-Trench G; Dunning AM; Pharoah PD; Kristensen V; Hall P; Easton DF; Pastinen T; Nord S; Simard J Oncotarget; 2016 Dec; 7(49):80140-80163. PubMed ID: 27792995 [TBL] [Abstract][Full Text] [Related]
27. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL; Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925 [TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Hughes DJ; Ginolhac SM; Coupier I; Barjhoux L; Gaborieau V; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Sobol H; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Yannoukakos D; Mazoyer S; Lynch HT; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM Int J Cancer; 2005 Nov; 117(2):230-3. PubMed ID: 15900600 [TBL] [Abstract][Full Text] [Related]
33. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241 [TBL] [Abstract][Full Text] [Related]
34. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF; Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973 [TBL] [Abstract][Full Text] [Related]
35. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Lecarpentier J; Noguès C; Mouret-Fourme E; Gauthier-Villars M; Lasset C; Fricker JP; Caron O; Stoppa-Lyonnet D; Berthet P; Faivre L; Bonadona V; Buecher B; Coupier I; Gladieff L; Gesta P; Eisinger F; Frénay M; Luporsi E; Lortholary A; Colas C; Dugast C; Longy M; Pujol P; Tinat J; ; Lidereau R; Andrieu N Breast Cancer Res; 2012 Jul; 14(4):R99. PubMed ID: 22762150 [TBL] [Abstract][Full Text] [Related]
36. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
37. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy. Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686 [TBL] [Abstract][Full Text] [Related]